The challenge of hyponatremia

Journal of the American Society of Nephrology

Volumn 23, Issue 7, 2012, Pages 1140-1148

  Adrogué, Horacio J ^a,b   Madias, Nicolaos E ^c,d  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

CLINICAL FEATURE; DEHYDRATION; DEMYELINATION; FLUID THERAPY; HUMAN; HYPONATREMIA; LABORATORY DIAGNOSIS; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SODIUM BLOOD LEVEL; TREATMENT PLANNING;

EID: 84863529563     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012020128     Document Type: Review

References (62)

1. Waikar SS, Mount DB, Curhan GC: Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122: 857-865, 2009
2. Upadhyay A, Jaber BL, Madias NE: Epidemiology of hyponatremia. Semin Nephrol 29: 227-238, 2009
3. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE: Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 170: 294-302, 2010
4. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD: Mortality and serum sodium: Do patients die from or with hyponatremia? Clin J Am Soc Nephrol 6: 960-965, 2011
5. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G: Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119: 71, e1-e8, 2006
6. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G: Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101: 583-588, 2008 (Pubitemid 351912001)
7. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE: Hyponatremia-induced osteoporosis. J Bone Miner Res 25: 554-563, 2010
8. Kinsella S, Moran S, Sullivan MO, Molloy MGM, Eustace JA: Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 5: 275-280, 2010
9. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C; SALT Investigators: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355: 2099-2112, 2006 (Pubitemid 44749318)
10. Adrogué HJ: Consequences of inadequate management of hyponatremia. Am J Nephrol 25: 240-249, 2005
11. Berl T, Rastegar A: A patient with severe hyponatremia and hypokalemia: Osmotic demyelination following potassium repletion. Am J Kidney Dis 55: 742-748, 2010
12. Koczmara C, Wade AW, Skippen P, Campigotto MJ, Streitenberger K, Carr R, Wong E, Robertson K: Hospital-acquired acute hyponatremia and reports of pediatric deaths. Dynamics 21: 21-26, 2010
13. Singh DK, Rastogi M, Husain M: Central pontine myelinolysis in a pediatric head injury patient. Pediatr Neurosurg 46: 51-53, 2010
14. Tullu MS, Deshmukh I, Muranjan MN, Kher AS, Lahiri KR: Extrapontine myelinolysis in a child with nephrotic syndrome. Pediatr Neurol 43: 139-141, 2010
15. Norenberg MD: Central pontine myelinolysis: Historical and mechanistic considerations. Metab Brain Dis 25: 97-106, 2010
16. Odier C, Nguyen DK, Panisset M: Central pontine and extrapontine myelinolysis: From epileptic and other manifestations to cognitive prognosis. J Neurol 257: 1176-1180, 2010
17. Sterns RH, Hix JK, Silver S: Treatment of hyponatremia. Curr Opin Nephrol Hypertens 19: 493-498, 2010
18. Perianayagam A, Sterns RH, Silver SM, Grieff M, Mayo R, Hix J, Kouides R: DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 3: 331-336, 2008
19. Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G: Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 76: 614-621, 2009
20. Sterns RH, Hix JK: Overcorrection of hyponatremia is a medical emergency. Kidney Int 76: 587-589, 2009
21. Sterns RH, Hix JK, Silver S: Treating profound hyponatremia: A strategy for controlled correction. Am J Kidney Dis 56: 774-779, 2010
22. Sood L, Hix JK, Sterns RH: 3% saline and DDAVP: A simple strategy for safe correction of severe hyponatremia [Abstract FR-OR238]. J Am Soc Nephrol 22, 2011: 57A
23. Edelman IS, Leibman J, O'Meara MP, Birkenfeld LW: Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 37: 1236-1256, 1958
24. Overgaard-Steensen C, Larsson A, Bluhme H, Tønnesen E, Frøkiaer J, Ring T: Edelman's equation is valid in acute hyponatremia in a porcine model: Plasma sodium concentration is determined by external balances of water and cations. Am J Physiol Regul Integr Comp Physiol 298: R120-R129, 2010
25. Adrogué HJ, Madias NE: Hyponatremia. N Engl J Med 342: 1581-1589, 2000 (Pubitemid 30340505)
26. Ellison DH, Berl T: Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356: 2064-2072, 2007 (Pubitemid 46789896)
27. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH: Hyponatremia treatment guidelines 2007: Expert panel recommendations. Am J Med 120[Suppl 1]: S1-S21, 2007 (Pubitemid 350027722)
28. Adrogué HJ, Wesson DE: Salt & Water, Boston, Blackwell Scientific, 1994
29. Furst H, Hallows KR, Post J, Chen S, Kotzker W, Goldfarb S, Ziyadeh FN, Neilson EG: The urine/plasma electrolyte ratio: A predictive guide to water restriction. Am J Med Sci 319: 240-244, 2000 (Pubitemid 30396584)
30. Berl T: Treating hyponatremia: Damned if we do and damned if we don't. Kidney Int 37: 1006-1018, 1990
31. Sterns RH, Nigwekar SU, Hix JK: The treatment of hyponatremia. Semin Nephrol 29: 282-299, 2009
32. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS: Hyponatremia among runners in the Boston Marathon. N Engl J Med 352: 1550-1556, 2005
33. Rosner MH: Exercise-associated hyponatremia. Semin Nephrol 29: 271-281, 2009
34. Chow KM, Kwan BC, Szeto CC: Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc 96: 1305-1308, 2004 (Pubitemid 39318958)
35. Mount DB: The brain in hyponatremia: Both culprit and victim. Semin Nephrol 29: 196-215, 2009
36. Gankam Kengne F, Nicaise C, Soupart A, Boom A, Schiettecatte J, Pochet R, Brion JP, Decaux G: Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol 22: 1834-1845, 2011
37. Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS, Lee SG: Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol 62: 362-368, 2009
38. Berl T: Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol 19: 1076-1078, 2008
39. 2 receptor antagonist, in hyponatremia. Am J Kidney Dis 50: 184-187, 2007
40. Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, Czerwiec FS; SALTWATER Investigators: Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol 21: 705-712, 2010
41. Jaber BL, Almarzouqi L, Borgi L, Seabra VF, Balk EM, Madias NE: Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia. Am J Med 124: 977.e1-9, 2011
42. Nemerovski C, Hutchinson DJ: Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: A clinical review. Clin Ther 32: 1015-1032, 2010
43. Josiassen RC, Curtis J, Filmyer DM, Audino B, Skuban N, Shaughnessy RA: Tolvaptan: A new tool for the effective treatment of hyponatremia in psychotic disorders. Expert Opin Pharmacother 11: 637-648, 2010
44. Greenberg A, Lehrich RW: Treatment of chronic hyponatremia: Now we know how, but do we know when or if? J Am Soc Nephrol 21: 552-555, 2010
45. Gross PA, Wagner A, Decaux G: Vaptans are not the mainstay of treatment in hyponatremia: Perhapsnot yet. Kidney Int 80: 594-600, 2011
46. Sterns R, Hix J: Hyponatremia: vasopressin antagonists in hyponatremia: More data needed. Nat Rev Nephrol 7: 132-133, 2011
47. Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L, Gafter U: Vasopressin receptor antagonists for the treatment of hyponatremia: Systematic review and meta-analysis. Am J Kidney Dis 56: 325-337, 2010
48. Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM: Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: A single-centre experience. Nephrol Dial Transplant 25: 1524-1531, 2010
49. Decaux G: The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Semin Nephrol 29: 239-256, 2009
50. Hijab S, Havalad S, Snyder AK: The role of organic osmolytes in the response of cultured astrocytes to hyperosmolarity. Am J Ther 18: 366-370, 2011
51. Suzuki H, Sugimura Y, Iwama S, Suzuki H, Nobuaki O, Nagasaki H, Arima H, Sawada M, Oiso Y: Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol 21: 2090-2098, 2010
52. Gankam-Kengne F, Soupart A, Pochet R, Brion JP, Decaux G: Minocycline protects against neurologic complications of rapid correction of hyponatremia. J Am Soc Nephrol 21: 2099-2108, 2010
53. Adrogué HJ, Madias NE: Aiding fluid prescription for the dysnatremias. Intensive Care Med 23: 309-316, 1997 (Pubitemid 27129997)
54. Adrogué HJ, Madias NE: Quantitative projection for the impact of measured water and electrolyte losses on serum sodium concentration for managing hyponatremia and hypernatremia [Abstract]. J Am Soc Nephrol 15: 781, 2004
55. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MR, Boyden CM, Body composition in normal adults. In: The Body Cell Mass and Its Supporting Environment, Philadelphia, London, W.B. Saunders, 1963, pp 58-159
56. Bhave G, Neilson EG: Body fluid dynamics: Back to the future. J Am Soc Nephrol 22: 2166-2181, 2011
57. Charney AN, Donowitz M: Gastrointestinal influences on hydrogen ion balance. In: Acid-Base Disorders and Their Treatment, edited by Gennari FJ, Adrogué HJ, Galla JH, Madias NE, Boca Raton, FL, Taylor & Francis, 2005, pp 209-240
58. Liamis G, Kalogirou M, Saugos V, Elisaf M: Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 21: 1564-1569, 2006 (Pubitemid 43834638)
59. Ring T: Does the Adrogue-Madias formula accurately predict serum sodium levels in patients with dysnatremias? Nat Clin Pract Nephrol 2: 674-675, 2006
60. Berl T: The Adrogue-Madias formula revisited. Clin J Am Soc Nephrol 2: 1098-1099, 2007
61. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH: Hypertonic saline for hyponatremia: Risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2: 1110-1117, 2007
62. Kamel KS, Halperin ML: Managing overly rapid correction of chronic hyponatremia: An ounce of prevention or a pound of cure? J Am Soc Nephrol 21: 2015-2016, 2010